earnings
EY
NASDAQ · EYPT
EyePoint Pharmaceuticals, Inc.
Healthcare · Biotechnology
$14.75
Up+$1.27 (+9.42%)
Updated Aug 16, 2026, 8:59 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.11B
- P/E ratio
- -5.5
- Dividend yield
- 0.00%
- 52-week range
- $9.65 – $19.11
- Volume
- 2.51M
- Avg. volume
- 1.29M
Price performance
EYPT price history
1M range · 20 trading sessions · Daily adjusted prices
EYPT closed at $14.75 after 20 trading sessions, up 16.51% for the selected period.
- Last close
- $14.75
- Period change
- +16.51%
- Period low
- $11.67
- Period high
- $14.75
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 14, 2026 | $13.53 | $14.76 | $13.40 | $14.75 | 2.51M |
| Aug 13, 2026 | $13.59 | $13.6938 | $13.25 | $13.48 | 1.2M |
| Aug 12, 2026 | $13.05 | $13.77 | $13.02 | $13.53 | 2.26M |
| Aug 11, 2026 | $13.105 | $13.105 | $12.37 | $13.05 | 2.06M |
| Aug 10, 2026 | $14.22 | $14.32 | $13.02 | $13.07 | 1.76M |
| Aug 7, 2026 | $13.04 | $14.08 | $13.0286 | $13.89 | 1.66M |
| Aug 6, 2026 | $12.25 | $13.03 | $12.005 | $12.83 | 2.24M |
| Aug 5, 2026 | $11.88 | $12.74 | $11.849 | $12.25 | 2.45M |
| Aug 4, 2026 | $12.44 | $12.70 | $11.54 | $11.67 | 2.93M |
| Aug 3, 2026 | $12.34 | $12.51 | $12.02 | $12.42 | 1.48M |
| Jul 31, 2026 | $12.81 | $12.83 | $12.04 | $12.25 | 1.71M |
| Jul 30, 2026 | $12.17 | $13.00 | $11.79 | $12.86 | 1.56M |
| Jul 29, 2026 | $11.98 | $12.355 | $11.555 | $11.92 | 2.05M |
| Jul 28, 2026 | $12.34 | $12.53 | $11.72 | $11.96 | 1.7M |
| Jul 27, 2026 | $12.48 | $13.025 | $12.17 | $12.41 | 1.39M |
| Jul 24, 2026 | $12.45 | $12.4975 | $12.06 | $12.19 | 1.47M |
| Jul 23, 2026 | $12.45 | $12.89 | $12.295 | $12.47 | 1.28M |
| Jul 22, 2026 | $12.81 | $13.04 | $12.52 | $12.66 | 1.06M |
| Jul 21, 2026 | $12.66 | $13.23 | $12.45 | $13.05 | 1.59M |
| Jul 20, 2026 | $13.27 | $13.79 | $12.65 | $12.66 | 1.1M |
Latest EYPT news
The latest Smart Investors Daily articles mentioning EYPT.
Stock researchCompany · Forecast
Loading stock research…